A Swedish artificial intelligence startup has secured $20 million in Series B funding, bringing its total raised to $35 million. The company, which specializes in automated medical technology solutions, plans to use the capital to expand across European markets and accelerate product development.
The funding round was led by Nordic venture capital firm Northzone, with participation from existing investors Atomico and several new strategic healthcare investors.
Focus on Automated Medical Technology
The company has developed AI-powered systems for automating diagnostic imaging analysis, reducing the time radiologists spend on routine cases while improving detection rates for early-stage abnormalities.
Their technology is now deployed in hospitals across Sweden, Norway, and Denmark, with plans to expand into Germany, the UK, and the Netherlands over the next 18 months.
"We see automation as the key to addressing the growing shortage of radiologists while actually improving diagnostic quality. This funding allows us to prove the model at scale."
Regulatory Path
A significant portion of the new funding will go toward regulatory approvals. The company has already achieved CE marking for the European market and is pursuing FDA clearance for the US market.
The regulatory investment reflects the broader trend of AI medical technology companies taking the approval path seriously, recognizing that clinical trust requires demonstrated safety and efficacy.
Growing Nordic AI Ecosystem
This funding adds to the growing evidence of a thriving AI startup ecosystem in the Nordic region. The combination of strong technical talent, supportive government policies, and proximity to healthcare systems willing to pilot new technology has created favorable conditions for AI healthcare companies.
With an experienced team and clear path to market, this startup represents the next generation of European AI companies with global ambitions.